Zynex (ZYXI) said late Wednesday that the temporary suspension of payments by Tricare will continue as its largest insurance customer conducts further review.
Zynex management appealed the suspension and presented its case in April to Tricare, the US Department of Defense's health care program administered through the Defense Health Agency.
The company's shares fell 5.6% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.